{"disease":{"id":"brca2-mutation","name":"brca2 mutation"},"drugs":{"marketed":[{"drug_id":"talazoparib-with-enzalutamide","indication_name":"Metastatic castration-resistant prostate cancer (mCRPC) with BRCA1, BRCA2, or ATM gene mutations","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Talazoparib with enzalutamide","generic_name":"talazoparib-with-enzalutamide","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"PARP enzymes and androgen receptor","drug_class":"PARP inhibitor and androgen receptor inhibitor","quality_score":10,"revenue":"2194","mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07253051","title":"BRCA Mutation Carriers' Platform a Multicenter Study","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT03351803","title":"BRCA Founder OutReach (BFOR) Study","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":5412,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT02993068","title":"Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible)","phase":"NA","overall_status":"SUSPENDED","enrollment_count":5200,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT04294927","title":"TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention","phase":"NA","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"University Medical Center Nijmegen","has_results":false},{"nct_id":"NCT03702309","title":"Liquid Biopsy Evaluation and Repository Development at Princess Margaret","phase":"","overall_status":"RECRUITING","enrollment_count":2500,"lead_sponsor_name":"University Health Network, Toronto","has_results":false},{"nct_id":"NCT04012229","title":"IMpact of Breast cAncer Gene Status on Survival in Adjuvant Breast Cancer (IMBASSA)","phase":"","overall_status":"COMPLETED","enrollment_count":2295,"lead_sponsor_name":"Centre Hospitalier Universitaire de Besancon","has_results":false},{"nct_id":"NCT04585074","title":"Prospective Study of MAstectomy With Reconstruction Including Robot Endoscopic Surgery","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Severance Hospital","has_results":false},{"nct_id":"NCT04190667","title":"Homologous Recombination Deficiency Status in Epithelial Ovarian Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":1300,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT05420064","title":"An Intervention to Increase Genetic Testing in Families Who May Share a Gene Mutation Related to Cancer Risk and An Intervention to Help Patients and Their Primary Care Providers Stay Up-to-date About Uncertain Genetic Test Results","phase":"NA","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT04095195","title":"Registry of Subjects at Risk of Pancreatic Cancer","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Associazione Italiana per lo Studio del Pancreas","has_results":false},{"nct_id":"NCT05410951","title":"LobularCard Trial: Searching for Novel Germline Mutations in Lobular Breast Cancer Patients","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":800,"lead_sponsor_name":"European Institute of Oncology","has_results":false},{"nct_id":"NCT03835793","title":"Health After eaRly Menopause Due to Oophorectomy","phase":"","overall_status":"UNKNOWN","enrollment_count":750,"lead_sponsor_name":"The Netherlands Cancer Institute","has_results":false},{"nct_id":"NCT04108117","title":"Surgical and Oncologic Outcomes After Robotic Nipple Sparing Mastectomy and Immediate Reconstruction","phase":"","overall_status":"COMPLETED","enrollment_count":659,"lead_sponsor_name":"Severance Hospital","has_results":false},{"nct_id":"NCT03211611","title":"Management of Women With BRCA1/2 Mutation","phase":"","overall_status":"COMPLETED","enrollment_count":600,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT03066856","title":"Dietary Intervention and BRCA Penetrance","phase":"NA","overall_status":"COMPLETED","enrollment_count":502,"lead_sponsor_name":"Fondazione IRCCS Istituto Nazionale dei Tumori, Milano","has_results":false},{"nct_id":"NCT02760849","title":"Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":374,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT02194387","title":"Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family Members","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":337,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT05898009","title":"Contribution of Oncogenetics in Breast Cancer in Reunion Epidemiology of Breast Cancer in Reunion: Study of the Reunion Mutation on BRCA2","phase":"NA","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Centre Hospitalier Universitaire de la Réunion","has_results":false},{"nct_id":"NCT03570125","title":"BRCA Main Home Nutritional Intervention-random Study","phase":"NA","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo","has_results":false},{"nct_id":"NCT06380660","title":"Study of ACE-86225106 to Treat Patients With Advanced Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":298,"lead_sponsor_name":"Acerand Therapeutics (Shanghai) Limited","has_results":false},{"nct_id":"NCT03470402","title":"Decision Support for BRCA Testing in Ethnically Diverse Women","phase":"NA","overall_status":"COMPLETED","enrollment_count":276,"lead_sponsor_name":"Columbia University","has_results":false},{"nct_id":"NCT05748353","title":"Endocrine Disruptors and Life STILe in Breast Cancer Development","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":275,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT04683068","title":"Promoting Men's Adherence to BRCA1/2 Germline Genetic Testing","phase":"NA","overall_status":"COMPLETED","enrollment_count":264,"lead_sponsor_name":"European Institute of Oncology","has_results":false},{"nct_id":"NCT05537844","title":"Longitudinal Sample Collection to Investigate Adaptation and Evolution of Ovarian High-grade Serous Carcinoma","phase":"","overall_status":"UNKNOWN","enrollment_count":250,"lead_sponsor_name":"Liz-Anne Lewsley","has_results":false},{"nct_id":"NCT04983628","title":"Molecular Profiling in Prostate Cancer","phase":"","overall_status":"UNKNOWN","enrollment_count":250,"lead_sponsor_name":"Hellenic Cooperative Oncology Group","has_results":false},{"nct_id":"NCT04890327","title":"Web-based Family History Tool","phase":"NA","overall_status":"COMPLETED","enrollment_count":250,"lead_sponsor_name":"Weill Medical College of Cornell University","has_results":false},{"nct_id":"NCT03544983","title":"Genetic Education in BRCA Families","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":240,"lead_sponsor_name":"Georgetown University","has_results":false},{"nct_id":"NCT04651920","title":"A Study on Association Between HR Genes and the HRD Status in Chinese Epithelial Ovarian Cancer","phase":"","overall_status":"COMPLETED","enrollment_count":240,"lead_sponsor_name":"Lei Li","has_results":false},{"nct_id":"NCT01905592","title":"A Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":216,"lead_sponsor_name":"Tesaro, Inc.","has_results":true},{"nct_id":"NCT04668521","title":"Multifactorial Risk Assessment for Breast & Ovarian Cancer Risk Detection","phase":"","overall_status":"TERMINATED","enrollment_count":215,"lead_sponsor_name":"Aspira Women's Health","has_results":false},{"nct_id":"NCT06201234","title":"Evaluating the Addition of Elacestrant (Oral SERD) to Olaparib (PARP-inhibitor) in Patients With Advanced/Metastatic HR+/HER2- Breast Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":176,"lead_sponsor_name":"GBG Forschungs GmbH","has_results":false},{"nct_id":"NCT04055038","title":"Efficacy of Platinum-based Chemotherapy in Platinum-resistant Ovarian Cancer) (EPITOC)","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":164,"lead_sponsor_name":"Blokhin's Russian Cancer Research Center","has_results":false},{"nct_id":"NCT02208375","title":"mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and Ovarian","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":159,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT02286687","title":"Talazoparib in Treating Patients With Recurrent, Refractory, Advanced, or Metastatic Cancers and Alterations in the BRCA Genes","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":150,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT07499999","title":"Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast Cancer","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":140,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":false},{"nct_id":"NCT03344965","title":"Olaparib In Metastatic Breast Cancer","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":114,"lead_sponsor_name":"Beth Israel Deaconess Medical Center","has_results":false},{"nct_id":"NCT01219075","title":"Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast Cancer","phase":"NA","overall_status":"COMPLETED","enrollment_count":110,"lead_sponsor_name":"University of Southern California","has_results":false},{"nct_id":"NCT04038502","title":"Carboplatin or Olaparib for BRcA Deficient Prostate Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"VA Office of Research and Development","has_results":false},{"nct_id":"NCT00892736","title":"Veliparib in Treating Patients With Malignant Solid Tumors That Do Not Respond to Previous Therapy","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":98,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT04566952","title":"Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":68,"lead_sponsor_name":"Xiaoxiang Chen","has_results":false},{"nct_id":"NCT03845296","title":"Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":64,"lead_sponsor_name":"SWOG Cancer Research Network","has_results":true},{"nct_id":"NCT02957981","title":"The Genetic Education for Men Trial: Web-Based Education vs. Standard Care","phase":"NA","overall_status":"COMPLETED","enrollment_count":63,"lead_sponsor_name":"Georgetown University","has_results":false},{"nct_id":"NCT04584255","title":"Niraparib + Dostarlimab In BRCA Mutated Breast Cancer","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":62,"lead_sponsor_name":"Dana-Farber Cancer Institute","has_results":false},{"nct_id":"NCT04090567","title":"Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT05264532","title":"Usefulness of Video-Based Intervention in Helping Participants Encourage Their Families to Get Tested for BRCA Gene Mutations","phase":"NA","overall_status":"COMPLETED","enrollment_count":58,"lead_sponsor_name":"Ohio State University Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT04428736","title":"Evaluating Cascade Communication Methods","phase":"","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"University of Pennsylvania","has_results":false},{"nct_id":"NCT01540565","title":"Veliparib in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true},{"nct_id":"NCT03377556","title":"Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":51,"lead_sponsor_name":"SWOG Cancer Research Network","has_results":true},{"nct_id":"NCT03546972","title":"Diabetes Prevention Program With or Without Hunger Training in Helping to Lower Breast Cancer Risk in Obese Participants","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":51,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT03428399","title":"Depression and Body Image Distress Following Mastectomy With Reconstruction","phase":"","overall_status":"COMPLETED","enrollment_count":51,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}